Cipaglucosidase Alfa-Atga

enzyme replacement therapy (ERT): A treatment that provides the body with a working version of an enzyme it cannot make enough of on its own.

Pompe disease: A rare inherited disorder in which the body cannot properly break down glycogen (stored sugar) due to a missing or deficient enzyme, leading to muscle damage.

late-onset Pompe disease: A form of Pompe disease that typically appears in childhood or adulthood, progressing more slowly than the infantile form but still causing significant muscle and breathing problems.

lysosomal acid alpha-glucosidase (GAA): The enzyme normally responsible for breaking down glycogen inside the cell's lysosomes; it is deficient in people with Pompe disease.

glycogen: A form of sugar stored in the body's cells and tissues; it builds up abnormally in Pompe disease.

lysosome: A compartment inside cells that acts like a recycling center, breaking down waste products and large molecules like glycogen.

anaphylaxis: A severe, life-threatening allergic reaction that can cause breathing difficulty, throat swelling, and a dangerous drop in blood pressure.

infusion-associated reaction (IAR): A reaction that occurs during or shortly after an intravenous infusion, ranging from mild symptoms like chills and rash to severe reactions like difficulty breathing.

hypersensitivity reaction: An overreaction of the immune system to a drug or substance, ranging from mild symptoms like hives to severe reactions like anaphylaxis.

intravenous (IV) infusion: Delivery of a medication directly into a vein through a needle or catheter, usually given slowly over a period of time.

contraindicated: A drug or treatment that must not be used in a particular situation or patient group because the risks outweigh any potential benefit.

antihistamine: A medication used to reduce allergic reactions by blocking histamine, a chemical the body releases during an allergic response.

corticosteroid: A type of anti-inflammatory medication (such as a steroid) used to reduce immune responses and treat inflammation.

antipyretic: A medication that reduces fever.

half-life: The time it takes for the concentration of a drug in the body to be reduced by half; shorter half-lives mean the drug clears the body more quickly.

pharmacokinetics: The study of how the body absorbs, distributes, breaks down, and eliminates a drug over time.

pharmacodynamics: The study of what a drug does to the body — its measurable effects and how it produces them.

AUC (area under the curve): A measure of total drug exposure in the bloodstream over time; a higher AUC generally means the body is exposed to more of the drug.

bis-M6P: A molecular tag on cipaglucosidase alfa-atga that allows it to bind strongly to specific receptors on cell surfaces, helping the drug get inside cells efficiently.

M6P receptor: A protein on the surface of cells that binds mannose-6-phosphate tags, helping shuttle enzymes like cipaglucosidase alfa-atga into the cell's lysosomes.

miglustat: The active ingredient in Opfolda; it stabilizes cipaglucosidase alfa-atga in the bloodstream after infusion, reducing its breakdown.

urinary Glc4 (glucose tetrasaccharide): A breakdown product of excess glycogen that is measured in urine as a marker of how much glycogen is accumulating in the body; lower levels suggest the treatment is working.

fluid volume overload: A condition where there is too much fluid in the body's circulation, which can stress the heart and lungs.

embryo-fetal toxicity: Harm caused to a developing embryo or fetus by a drug taken during pregnancy.

NOAEL (No Observed Adverse Effect Level): The highest dose in an animal study at which no harmful effects were observed.

immunogenicity: The tendency of a drug to trigger an immune response — such as the formation of antibodies — which can affect how well it works or cause reactions.

antibody titer: A measure of how much of a specific antibody is present in the blood; high titers against a drug can sometimes reduce its effectiveness or increase the risk of reactions.

pruritus: Itching of the skin.

pyrexia: Fever — an elevated body temperature.

dyspnea: Shortness of breath or difficulty breathing.

tachycardia: A faster-than-normal heart rate.

urticaria: Hives — raised, itchy welts on the skin, often a sign of an allergic reaction.

bronchospasm: A sudden tightening of the muscles around the airways, causing narrowing and difficulty breathing.

myalgia: Muscle pain or aching.

dysgeusia: A change or distortion in the sense of taste.

paresthesia: An abnormal sensation such as tingling, numbness, or a 'pins and needles' feeling.

desensitization: A process of gradually re-exposing a patient to a drug they reacted to, under careful supervision, to reduce or eliminate the allergic response.

opalescent: Having a milky, iridescent appearance — used to describe the look of a reconstituted solution.

aseptic technique: A method of preparing or handling medications in a way that prevents contamination with bacteria or other microorganisms.

catabolic pathway: A biological process in which the body breaks down larger molecules into smaller ones, typically to produce energy or eliminate waste.

accumulation: A buildup of a medicine in the body when new doses are taken before earlier ones are fully removed.

Adverse Reactions: Unwanted or harmful effects that people experienced while taking a medicine, listed on its official label.

AUC: A measure of total drug exposure over time, showing how much medicine the blood is exposed to overall.

baseline: A person's starting condition, measured before treatment begins, used to see how much they change later on.

Boxed Warning: The strongest safety warning the FDA can require, set inside a bold black border because the risk it describes can be very serious.

clearance: How quickly the body removes a medicine from the blood, usually through the liver and kidneys.

contraception: Methods used to prevent pregnancy, such as birth control pills, condoms, or an intrauterine device.

diarrhea: Loose, watery bowel movements that happen more often than normal.

Distribution: How a medicine spreads from the blood into the body's tissues and organs after it is absorbed.

Dosage and Administration: The label section explaining how much of a medicine to use and how to take or give it.

fetal harm: Injury or damage to a developing baby while it is growing inside the womb.

flushing: Temporary redness and warmth of the skin, often on the face and neck, from widening of small blood vessels.

hypersensitivity: An overreaction of the body's defense system to a substance, causing symptoms such as rash, swelling, or trouble breathing.

Indications and Usage: The label section stating which medical conditions the FDA has officially approved the medicine to treat, prevent, or manage.

infusion: Slowly delivering fluid or medicine into a vein over a period of time, usually through a drip.

intravenous: Given directly into a vein through a needle or thin tube; often written as IV.

NDC: A unique number that identifies a specific medicine, its maker, strength, and package size.

nursing infant: A baby who is being fed breast milk.

Prescribing Information: The official, detailed document approved by the FDA that tells health professionals how to use a prescription medicine.

reproductive potential: The ability to have children, meaning a person who could become pregnant or could father a child.

Warnings and Precautions: The label section describing serious risks to know about and safety steps to follow while using a medicine.